<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03738514</url>
  </required_header>
  <id_info>
    <org_study_id>GDCRI/ACM/PG/Ph.D/5/2016-2017</org_study_id>
    <nct_id>NCT03738514</nct_id>
  </id_info>
  <brief_title>Comparison of Efficacy of 5% Fluorocalcium Phosphosilicate Dentifrice and Potassium Nitrate Dentifrice on Dentinal Hypersensitivity</brief_title>
  <official_title>Comparison Of Efficacy Of Dentifrice Containing 5% Fluorocalcium Phosphosilicate With Dentifrice Containing Potassium Nitrate And Placebo On Dentinal Hypersensitivity: A Triple Masked Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Government Dental College and Research Institute, Bangalore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Group Pharma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Government Dental College and Research Institute, Bangalore</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of this study was to assess and compare the efficacy of a dentifrice containing 5% fluoro
      calcium phosphosilicate and dentifrice containing potassium nitrate on Dentinal
      Hypersensitivity (DH) compared to a placebo over a period of 6 weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 120 subjects were divided into 3 groups randomly. Group 1 was given the dentifrice
      containing 5% fluoro calcium phosphosilicate ,Group 2 was given the dentifrice containing
      potassium nitrate and group 3 was given placebo. Sensitivity scores (VAS score) were recorded
      at baseline, 2 weeks, 6 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 22, 2017</start_date>
  <completion_date type="Actual">February 22, 2018</completion_date>
  <primary_completion_date type="Actual">February 9, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale score for Dentinal Hypersensitivity</measure>
    <time_frame>Change in VAS score from Baseline to 12 weeks</time_frame>
    <description>Based on a 10-cm VAS score which was used to measure tooth sensitivity, a pain-free response was allotted a score of zero whereas a score of 10 was given to subjects with excruciating pain or discomfort.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Dentinal Hypersensitivity</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>dentifrice containing 5% fluorocalcium phospho silicate prescribed and VAS score assessed at Baseline, 2 weeks, 6 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>dentifrice containing 5% potassium nitrate prescribed and VAS score assessed at Baseline, 2weeks, 6 weeks .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>dentifrice without the active ingredient prescribed and VAS score assessed at Baseline, 2weeks, 6 weeks .</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>5% fluorocalcium phosphosilicate dentifrice</intervention_name>
    <description>dentifrice containing 5% fluorocalcium phosphosilicate and VAS score assessed at Baseline, 2 weeks, 6 weeks</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>5% potassium nitrate dentifrice</intervention_name>
    <description>5% potassium nitrate dentifrice and VAS score assessed at Baseline, 2weeks, 6 weeks.</description>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo dentrifice</intervention_name>
    <description>placebo dentifrice and VAS score assessed at Baseline, 2weeks, 6 weeks</description>
    <arm_group_label>Group 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The volunteers selected at baseline were in good general health and should have at
             least 20 natural permanent teeth and history of hypersensitivity to hot, cold, sour
             stimuli on at least two teeth with a VAS score of â‰¥4.

        Exclusion Criteria:

          -  Patients with active cervical caries or deep abrasion requiring cervical filling,
             chipped teeth or fractured cusps, tender tooth in same quadrant as the hypersensitive
             teeth, Subjects using any type of desensitizing paste or desensitizing therapy for
             last 6 months, Pregnant/ lactating women or subjects with history of chronic use of
             anti-inflammatory and analgesic medications were excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Avani R Pradeep, MDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>GDCRI, Bangalore, INDIA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Periodontics, GDCRI Bangalore</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <zip>560002</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 9, 2018</study_first_submitted>
  <study_first_submitted_qc>November 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2018</study_first_posted>
  <last_update_submitted>November 9, 2018</last_update_submitted>
  <last_update_submitted_qc>November 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Government Dental College and Research Institute, Bangalore</investigator_affiliation>
    <investigator_full_name>Dr. A R Pradeep</investigator_full_name>
    <investigator_title>Head and Professor</investigator_title>
  </responsible_party>
  <keyword>Dentinal Hypersensitivity</keyword>
  <keyword>Visual Analogue Score</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

